Acetylcholinesterase inhibitor donepezil in the treatment of cognitive deficit in schizophrenia. Subanalysis of the active branch from Czech extended double blind study.

Full Abstract

The article mentions the conclusions of most evidential works investigating donepezil in the treatment of cognitive deficit in schizophrenia. It focuses on an analysis of a sub-group of 20 patients receiving treatment of the donepezil in an extended Czech double-blind placebo controlled study.

Author information

Author/s: Pérez, M (M); Tuma, I (I); Pytela, O (O); Kadlecová, E (E); Zemanová, M (M); Lenderová, Z (Z);

Affiliation: Department of Psychiatry, Hospital Havirov, Charles University, Prague, Faculty of Medicine, Hradec Kralove, Czech Republic. prim.psychiatrie(-atsign-)nsphav.cz

Journal and publication information

Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

Journal: European psychiatry : the journal of the Association of European Psychiatrists (Eur Psychiatry), published in France. (Language: eng)

Reference: 2006-Dec; vol 21 (issue 8) : pp 548-50

Dates: Created 2006/12/12; Completed 2007/02/23;

PMID: 16797936, status: MEDLINE (last retrieved date: 2/18/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.